Results 31 to 40 of about 29,014 (254)
Memantine-induced Myoclonus in a Patient with Alzheimer Disease
Tremor and Other Hyperkinetic Movements, 2015 Background: Myoclonus can be a clinical manifestation of numerous neurodegenerative disorders and an adverse drug reaction to medications used in their treatment.Case report: Herein, we report memantine-induced myoclonus in a patient with Alzheimer ...
Aditya A. Murgai, Mark S. LeDoux
doaj +1 more source
Dexmedetomidine versus Lignocaine in the Prevention of Etomidate-induced Myoclonus- A Randomised Double-blinded Study [PDF]
Journal of Clinical and Diagnostic Research, 2023 Introduction: Etomidate is a preferred induction agent owing to its stable haemodynamic profile, minimal respiratory side-effects, minimal histamine release, cerebral protection and its property of rapid onset and short duration.
Gojendra Rajkumar +7 more
doaj +1 more source
Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
Annals of Clinical and Translational Neurology, 2021 We present a female patient in her early twenties with global development delay, progressive ataxia, epilepsy, and myoclonus caused by a stop mutation in the SEMA6B gene.
Rebecca Herzog +7 more
doaj +1 more source
“Dancing belly” in an old diabetic lady
Journal of Family Medicine and Primary Care, 2020 Movement disorder, although rare, is increasingly being recognized as the initial presenting sign of the hyperglycemic state. Although chorea-ballism has frequently been reported among diabetics, monoballism is a very rare phenomenon.
Souvik Dubey +6 more
doaj +1 more source
Orthostatic Myoclonus-Clinical and Electrophysiological Features in a Large Retrospective Cohort. [PDF]
Mov Disord Clin PractAbstract Background Orthostatic myoclonus is characterized by irregular, lower limb myoclonic bursts during stance and is a major cause of postural instability and falls. However, studies are limited, and little is known about its pathophysiology. Objectives We sought to define the clinical and electrophysiological features of orthostatic myoclonus in ...
Nagaratnam SA +8 more
europepmc +2 more sources
, 2023 Myoclonus is often approached in different ways by epileptologists and movement disorder specialists, leading to confusion in the literature. Multiplicity and inconsistency over the past 2 centuries resulted in a lack of precision and ambiguity of the ...
Sterre Van Der Veen +5 more
core +1 more source
A Rare Neurological Complication of Ranolazine
Case Reports in Neurological Medicine, 2013 Myoclonus is not a known side effect of ranolazine. We report a case of myoclonus in a 72-year-old female who underwent cardiac catheterization for angina and was started on ranolazine after the procedure. Two days after ranolazine therapy on 1000 mg per
Jahan Porhomayon +2 more
doaj +1 more source
Molecular Basis for Activation to Inhibition Switching in Kv7.2 Channel Modulators
Angewandte Chemie, EarlyView.The paper describes the serendipitous discovery of chemical manipulation allowing the activator‐to‐inhibitor switching in Kv7.2 channel modulators. The molecular determinants driving this switch have been rationalized by multidisciplinary investigation encompassing synthetic and analytical chemistry, in silico methods, cryo‐EM analysis ...
Tania Ciaglia +20 more
wiley +2 more sources
Comparison of priming versus slow injection for reducing etomidate-induced myoclonus: a randomized controlled study [PDF]
Korean Journal of Anesthesiology, 2018 Background Etomidate injection is often associated with myoclonus. Etomidate injection technique influences the incidence of myoclonus. This study was designed to clarify which of the two injection techniques—slow injection or priming with etomidate—is ...
Parul Mullick +4 more
doaj +1 more source
Journal of Applied Pharmaceutical Research, 2022 Etomidate is a hypnotic drug used as an intravenous anaesthetic induction agent. Etomidate causes myoclonic movements in 50-80% patients after induction which makes it less desirable for induction.
Mukesh K Sunda +3 more
doaj +1 more source